We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Patient Advocacy Groups Can Help Speed Drug Development
Patient Advocacy Groups Can Help Speed Drug Development
June 23, 2005
Pharmaceutical companies can speed the drug-development process, including during clinical trial phases, by building relationships with patient advocacy groups, according to experts who spoke at the Biotechnology Industry Organization (BIO) annual conference in Philadelphia.